As of 2024-12-12, the Relative Valuation of Krystal Biotech Inc (KRYS) is 49.27 USD. This relative valuation is based on P/E multiples. With the latest stock price at 187.12 USD, the upside of Krystal Biotech Inc based on Relative Valuation is -73.7%.
The range of the Relative Valuation is 9.25 - 100.34 USD.
| Range | Selected | |
| Trailing P/E multiples | 39.8x - 55.1x | 47.4x |
| Forward P/E multiples | 25.9x - 42.0x | 34.0x |
| Fair Price | 9.25 - 100.34 | 49.27 |
| Upside | -95.1% - -46.4% | -73.7% |
| Date | P/E |
| 2024-12-04 | 103.03 |
| 2024-12-03 | 102.13 |
| 2024-12-02 | 107.03 |
| 2024-11-29 | 108.41 |
| 2024-11-27 | 108.13 |
| 2024-11-26 | 107.92 |
| 2024-11-25 | 106.84 |
| 2024-11-22 | 104.56 |
| 2024-11-21 | 100.10 |
| 2024-11-20 | 97.80 |
| 2024-11-19 | 97.67 |
| 2024-11-18 | 96.45 |
| 2024-11-15 | 93.76 |
| 2024-11-14 | 97.41 |
| 2024-11-13 | 101.16 |
| 2024-11-12 | 102.81 |
| 2024-11-11 | 107.56 |
| 2024-11-08 | 109.62 |
| 2024-11-07 | 101.84 |
| 2024-11-06 | 100.54 |
| 2024-11-05 | 95.78 |
| 2024-11-04 | 93.82 |
| 2024-11-01 | 96.86 |
| 2024-10-31 | 94.74 |
| 2024-10-30 | 96.39 |
| 2024-10-29 | 96.77 |
| 2024-10-28 | 97.14 |
| 2024-10-25 | 96.38 |
| 2024-10-24 | 96.09 |
| 2024-10-23 | 94.87 |
| 2024-10-22 | 96.21 |
| 2024-10-21 | 98.29 |
| 2024-10-18 | 98.40 |
| 2024-10-17 | 97.10 |
| 2024-10-16 | 97.63 |
| 2024-10-15 | 98.00 |
| 2024-10-14 | 98.62 |
| 2024-10-11 | 98.14 |
| 2024-10-10 | 95.09 |
| 2024-10-09 | 94.44 |
| 2024-10-08 | 96.01 |
| 2024-10-07 | 96.10 |
| 2024-10-04 | 97.26 |
| 2024-10-03 | 96.61 |
| 2024-10-02 | 97.41 |
| 2024-10-01 | 99.65 |
| 2024-09-30 | 99.96 |
| 2024-09-27 | 97.28 |
| 2024-09-26 | 97.97 |
| 2024-09-25 | 98.59 |